Metformin (glycinate)
Based on 136 publication(s) in Google Scholar
Metformin (1,1-Dimethylbiguanide) glycinate inhibits the mitochondrial respiratory chain in the liver, leading to AMPK activation and enhancing insulin sensitivity, and can be used in the study of type 2 diabetes. Metformin glycinate exerts central glucose-lowering effects by inhibiting Ras-related protein 1 (Rap1) in SF1 hypothalamic neurons. Metformin glycinate also inhibits liver oxidative stress, nitrosative stress, inflammation, and apoptosis caused by liver ischemia/reperfusion injury. In addition, Metformin glycinate regulates the expression of autophagy-related proteins by activating AMPK and inhibiting the mTOR signaling pathway, thereby inducing tumor cell autophagy and inhibiting the growth of renal cell carcinoma in vitro and in vivo.
For research use only. We do not sell to patients.
- CAS No.: 121369-64-0
- Formula: C6H16N6O2
- Molecular Weight:204.23
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Publications Citing Use of MedChemExpress (MCE) Metformin (glycinate)
More- Nature. 2025 Feb;638(8052):1112-1121. [Abstract]
- Circulation. 2023 Jan 10;147(2):158-174. [Abstract]
- Cell Res. 2023 Dec;33(12):904-922. [Abstract]
- Nat Commun. 2021 Aug 24;12(1):5106. [Abstract]
- Cell Death Differ. 2023 Jul;30(7):1829-1848. [Abstract]
- Acta Pharm Sin B. 2025 Dec;15(12):6382-6398. [Abstract]
- Autophagy. 2025 Nov 30:1-21. [Abstract]
- J Adv Res. 2026 Apr 18:S2090-1232(26)00332-2. [Abstract]
- J Adv Res. 2025 Mar 10:S2090-1232(25)00174-2. [Abstract]
- J Adv Res. 2024 Apr 14:S2090-1232(24)00155-3. [Abstract]
- Biomaterials. 2026 Jun:329:123966. [Abstract]
- Biomaterials. 2025 Aug:319:123210. [Abstract]
- Protein Cell. 2022 Nov;13(11):825-841. [Abstract]
- J Nanobiotechnology. 2025 Oct 14;23(1):670. [Abstract]
- Sci Adv. 2026 Jan 2;12(1):eadz9069. [Abstract]
- Sci Adv. 2025 May 16;11(20):eadq3870. [Abstract]
- Cell Rep Med. 2025 Jul 15;6(7):102211. [Abstract]
- Cancer Lett. 2026 Apr 28:644:218311. [Abstract]
- Cancer Lett. 2024 Aug 21:217177. [Abstract]
- Cancer Lett. 2024 Apr 10:587:216732. [Abstract]
- Cancer Lett. 2022 Apr 28:532:215582. [Abstract]
- Cell Death Dis. 2022 Apr 20;13(4):384. [Abstract]
- Genes Dis. 2025 Sep 10.
- Small Methods. 2020, 2000483.
- Cell Commun Signal. 2023 May 4;21(1):99. [Abstract]
- Int J Biol Macromol. 2025 Aug 21;323(Pt 1):147047. [Abstract]
- Acta Pharmacol Sin. 2022 Jun;43(6):1360-1371. [Abstract]
- Phytomedicine. 2025 Nov 27:150:157628. [Abstract]
- Phytomedicine. 2024 Jul:129:155679. [Abstract]
- Free Radic Biol Med. 2025 Sep:237:503-514. [Abstract]
- Food Res Int. 2025 Jun:211:116502. [Abstract]
- Sci Total Environ. 2024 Feb 20:912:169496. [Abstract]
- Brain Behav Immun. 2024 Jun 6:S0889-1591(24)00445-8. [Abstract]
- Emerg Microbes Infect. 2022 Dec;11(1):815-828. [Abstract]
- Food Sci Hum Wellness. 2026 Apr 3.
- Stem Cell Res Ther. 2025 Apr 18;16(1):186. [Abstract]
- Stem Cell Res Ther. 2025 Jan 23;16(1):20. [Abstract]
- PLoS Biol. 2025 Nov 24;23(11):e3003490. [Abstract]
- Aging Cell. 2026 Jan 20;25(2):e70352.
- Cell Rep. 2022 Nov 22;41(8):111707. [Abstract]
- J Med Chem. 2022 Sep 8;65(17):11818-11839. [Abstract]
- Anal Chem. 2025 Dec 19. [Abstract]
- Antioxidants. 2020 Oct 28;9(11):1057. [Abstract]
- Cell Mol Life Sci. 2023 Sep 9;80(10):283. [Abstract]
- Hum Reprod. 2020 May 1;35(5):1145-1158. [Abstract]
- Cancer Cell Int. 2024 Feb 14;24(1):74. [Abstract]
- Front Immunol. 2016 Dec 12:7:597. [Abstract]
- Chin Med. 2025 Nov 17;20(1):190. [Abstract]
- Biochem Pharmacol. 2023 Sep:215:115636. [Abstract]
- Food Funct. 2026 May 18. [Abstract]
- J Ethnopharmacol. 2026 Feb 28:357:120941. [Abstract]
- Liver Int. 2023 Jul;43(7):1577-1592. [Abstract]
- Biofactors. 2023 Jul-Aug;49(4):831-848. [Abstract]
- PLoS Pathog. 2024 Jun 21;20(6):e1012305. [Abstract]
- PLoS Pathog. 2023 Feb 3;19(2):e1011126. [Abstract]
- Int J Mol Sci. 2022 Dec 25;24(1):343. [Abstract]
- Biomolecules. 2025 Apr 9;15(4):556. [Abstract]
- Biomolecules. 2022 Mar 9;12(3):422. [Abstract]
- Int Immunopharmacol. 2026 Jun 8:185:116966. [Abstract]
- Int Immunopharmacol. 2025 May 20:159:114897. [Abstract]
- Am J Physiol Cell Physiol. 2024 Jun 1;326(6):C1590-C1603. [Abstract]
- Int Immunopharmacol. 2023 Sep 15;124(Pt A):110905. [Abstract]
- Eur J Pharmacol. 2023 Oct 5:956:175942. [Abstract]
- Eur J Pharmacol. 2023 Mar 15:943:175569. [Abstract]
- Cell Regen. 2022 May 5;11(1):19. [Abstract]
- Front Microbiol. 2026 Apr 13:17:1778515. [Abstract]
- Probiotics Antimicrob Proteins. 2025 Nov 26. [Abstract]
- Rheumatology (Oxford). 2023 Apr 3;62(4):1652-1661. [Abstract]
- Exp Gerontol. 2026 Jun 15:219:113157. [Abstract]
- J Inflamm Res. 2026 Feb 2:19:540176. [Abstract]
- J Inflamm Res. 2025 Mar 19:18:4087-4101. [Abstract]
- iScience. 2025 Apr 3;28(5):112344. [Abstract]
- J Inflamm (Lond). 2024 Jul 9;21(1):25. [Abstract]
- J Cell Physiol. 2025 Nov;240(11):e70110. [Abstract]
- J Drug Target. 2025 Jul 17:1-10. [Abstract]
- Sci Rep. 2025 Jul 26;15(1):27294. [Abstract]
- Biomedicines. 2024 Nov 4;12(11):2526. [Abstract]
- Aquaculture. 2024 Dec 15.
- J Virol. 2025 Aug 29:e0052925. [Abstract]
- Cell Signal. 2024 Jun:118:111125. [Abstract]
- Bone. 2025 Jan 28:193:117411. [Abstract]
- Mol Cell Endocrinol. 2024 Mar 1:582:112140. [Abstract]
- Exp Cell Res. 2026 Apr 1;457(1):114922. [Abstract]
- Mol Med Rep. 2023 Jan;27(1):17. [Abstract]
- J Diabetes Res. 2026;2026(1):e2226729. [Abstract]
- Appl Biochem Biotechnol. 2026 Mar 17. [Abstract]
- J Food Meas Charact. 2025 Sep 1.
- Biochim Biophys Acta Mol Cell Biol Lipids. 2025 May 12:159628. [Abstract]
- Front Oncol. 2021 Nov 22;11:762523. [Abstract]
- Environ Toxicol. 2024 Apr;39(4):2452-2465. [Abstract]
- Environ Toxicol. 2021 Dec;36(12):2414-2425. [Abstract]
- Naunyn Schmiedebergs Arch Pharmacol. 2025 Mar 4. [Abstract]
- J Neuropathol Exp Neurol. 2025 Aug 19:nlaf092. [Abstract]
- Curr Issues Mol Biol. 2025 Jul 3;47(7):515. [Abstract]
- Breast Cancer Res Treat. 2025 Jun;211(2):467-478. [Abstract]
- Mol Reprod Dev. 2024 Aug;91(8):e23768. [Abstract]
- Arch Biochem Biophys. 2022 Jun 15;722:109216. [Abstract]
- Oral Dis. 2025 Feb;31(2):468-481. [Abstract]
- J Appl Toxicol. 2026 Feb 2. [Abstract]
- Neuroscience. 2025 Jan 26:565:91-98. [Abstract]
- J Chromatogr B Analyt Technol Biomed Life Sci. 2024 Dec 28:1252:124446. [Abstract]
- J Orthop Surg Res. 2023 Nov 4;18(1):831. [Abstract]
- Genes (Basel). 2022 Dec 16;13(12):2384. [Abstract]
- Onco Targets Ther. 2020 May 19;13:4445-4455. [Abstract]
- J Integr Neurosci. 2026 Apr 13;25(4):47364. [Abstract]
- PLoS One. 2023 May 18;18(5):e0283943. [Abstract]
- Cell Biochem Biophys. 2025 Apr 4. [Abstract]
- Oncol Lett. 2021 Jan;21(1):31. [Abstract]
- Biochem Bioph Res Co. 2020 Dec 17;533(4):665-671. [Abstract]
- Biochem Cell Biol. 2023 Dec 1;101(6):523-530. [Abstract]
- Stem Cells Dev. 2021 Oct 15;30(20):1017-1027. [Abstract]
- Cancer Rep (Hoboken). 2025 Jul;8(7):e70245. [Abstract]
- Virus Genes. 2022 Apr;58(2):133-142. [Abstract]
- Rev Bras Farmacogn. 2025 Sep 4.
- Int J Morphol. 40(5):1152-1164, 2022.
- Res Sq. 2026 Jun 15.
- bioRxiv. 2026 May 18.
- bioRxiv. 2026 Mar 18.
- Res Sq. 2026 Feb 17.
- SSRN. 2025 Oct 14.
- University of Otago. 2025 Oct 7.
- bioRxiv. 2025 Aug 25:2025.08.21.671520. [Abstract]
- SSRN. 2025 Jul 8.
- Res Sq. 2025 Jul 13.
- bioRxiv. 2025 May 05.
- bioRxiv. 2025 March 21.
- SSRN. 2025 Jan 31.
- Res Sq. 2024 Jul 12.
- SSRN. 2024 May 30.
- bioRxiv. 2023 May 12.
- SSRN. 2023 Feb 27.
- Research Square Print. November 29th, 2022.
- Research Square Print. 2022 Aug.
- Ann Transl Med. 2021 Oct;9(20):1547. [Abstract]
- Research Square Preprint. 2020 Dec.
- Clinical Cancer Drugs. 2020 Apr.
-
RT-PCR
-
WB
-
WB
-
WB
-
WB
All AMPK Isoforms
More
Biological Activity
Metformin (1,1-Dimethylbiguanide) glycinate inhibits proliferation of ESCs in a concentration-dependent manner. The IC50 is 2.45 mM for A-ESCs and 7.87 mM for N-ESCs. Metformin glycinate shows pronounced effects on activation of AMPK signaling in A-ESCs from secretory phase than in cells from proliferative phase[3].
Metformin (0-500 μM) glycinate decreases glycogen synthesis in a dose-dependent manner with an IC50 value of 196.5 μM in cultured rat hepatocytes[4].
Metformin glycinate shows cell viability and cytotoxic effects on PC-3 cells with IC50 of 5 mM[5].
Metformin (1–50 mM; 0-120 h) glycinate significantly inhibites the proliferation of both 786-O and OS-RC-2 RCC cell lines in a dose- and time-dependent manner[7].
Metformin (5 mM; 0-48 h) glycinate stimulates AMPK and inhibited the mTOR signaling pathway in 786-O cells[7].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:786-O and OS-RC-2 cells
-
Concentration:1, 5, 10, 20 and 50 mM
-
Incubation Time:0-120 h
-
Result:Inhibited the growth of 786-O and OS-RC-2 cells by 10% and 14% at doses of 0.2 and 0.5 mM, respectively.
-
Cell Line:786-O cells
-
Concentration:5 mM
-
Incubation Time:0-48 h
-
Result:Reduced phosphorylation of S6K1 (Thr389) in a time-dependent manner, and thus reduced phosphorylation of ribosomal S6 protein (Ser235/236).
Activated AMPK in a time-dependent manner.
Metformin (> 900 mg/kg/day, p.o.) glycinate results in moribundity/mortality and clinical signs of toxicity in Crl:CD(SD) rats[2].
Metformin (200 mg/kg; i.p.; once a day for 6 consecutive days before induction of ischemia and at the beginning of reperfusion) glycinate significantly reduces the serum alanine aminotransferase (ALT) level in rats with ischemia-reperfusion model[6].
Metformin (250 mg/kg; i.p.; once daily for 22 days) glycinate significantly reduces the growth of 786-O cell xenograft tumors in nude mice[7].
When dissolved in PBS, the solution is strongly alkaline. Before animal administration, the pH needs to be adjusted to neutral (pH=7) with hydrochloric acid (e.g., 1M HCl).
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
CAS No. 121369-64-0
-
Molecular Weight 204.23
-
Formula C6H16N6O2
-
SMILES
O=C(CN)O.N=C(NC(N(C)C)=N)N
-
Synonyms
1,1-Dimethylbiguanide (glycinate)
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Publications (136)
-
Journal Impact Factor
-
Most Recent
-
Nature
2025 Feb;638(8052):1112-1121. PMID: 39814884
Metformin (glycinate) purchased from MedChemExpress. Usage Cited in: Nature. 2025 Feb;638(8052):1112-1121. [Abstract]
Metformin (2 mM; 16 h) significantly inhibits the mRNA expression of FOXM1 downstream genes (CDC25B, CCNA2) in HEK293T cells.
-
Circulation
Cannabinoid Receptor 2-Centric Molecular Feedback Loop Drives Necroptosis in Diabetic Heart Injuries. [Abstract]2023 Jan 10;147(2):158-174. PMID: 36448459
Metformin (glycinate) purchased from MedChemExpress. Usage Cited in: Circulation. 2023 Jan 10;147(2):158-174. [Abstract]
Metformin. Western blot analysis of CB2R in the heart from db/db diabetic (DM) mice at different ages.
-
Cell Res
Mannose antagonizes GSDME-mediated pyroptosis through AMPK activated by metabolite GlcNAc-6P. [Abstract]2023 Dec;33(12):904-922. PMID: 37460805
Metformin (glycinate) purchased from MedChemExpress. Usage Cited in: Cell Res. 2023 Dec;33(12):904-922. [Abstract]
Cells were treated with mannose, MK-8722 (1 μM) or Metformin (1 mM) for 6 h. GSDME was immunoprecipitated using anti-GSDME antibody, and then the phosphorylation levels of GSDME T6 were detected.
-
Nat Commun
PD-L1 degradation is regulated by electrostatic membrane association of its cytoplasmic domain. [Abstract]2021 Aug 24;12(1):5106. PMID: 34429434 -
Cell Death Differ
GAS5 protects against nonalcoholic fatty liver disease via miR-28a-5p/MARCH7/NLRP3 axis-mediated pyroptosis. [Abstract]2023 Jul;30(7):1829-1848. PMID: 37337032 -
Acta Pharm Sin B
2025 Dec;15(12):6382-6398. PMID: 41477334 -
Autophagy
Activation of chaperone-mediated autophagy suppresses glioblastoma by promoting wild-type IDH1/isocitrate dehydrogenase 1 degradation. [Abstract]2025 Nov 30:1-21. PMID: 41231102 -
J Adv Res
Dietary EGCG reshapes metabolic-epigenetic interplay to induce transgenerational host defense. [Abstract]2026 Apr 18:S2090-1232(26)00332-2. PMID: 42009104 -
J Adv Res
Discovery and identification of semaphorin 4D as a bioindicator of high fracture incidence in type 2 diabetic mice with glucose control. [Abstract]2025 Mar 10:S2090-1232(25)00174-2. PMID: 40073972
Metformin (glycinate) purchased from MedChemExpress. Usage Cited in: J Adv Res. 2025 Mar 10:S2090-1232(25)00174-2. [Abstract]
STAT3 levels in hBMSCs treated with metformin and the miR-140-3p inhibitor.
-
J Adv Res
Interplay between lipid dysregulation and ferroptosis in chondrocytes and the targeted therapy effect of metformin on osteoarthritis. [Abstract]2024 Apr 14:S2090-1232(24)00155-3. PMID: 38621621 -
Biomaterials
Microenvironment-engineered hydrogels drive osteo-angiogenic coupling to accelerate osteoporotic bone regeneration. [Abstract]2026 Jun:329:123966. PMID: 41520542 -
Biomaterials
Zn2+-driven metformin conjugated with siRNA attenuates osteoarthritis progression by inhibiting NF-κB signaling and activating autophagy. [Abstract]2025 Aug:319:123210. PMID: 40037209 -
Protein Cell
Genome-wide CRISPR screen identifies synthetic lethality between DOCK1 inhibition and metformin in liver cancer. [Abstract]2022 Nov;13(11):825-841. PMID: 35217990 -
J Nanobiotechnology
Biomimetic ferritin nanocages for synergistic co-delivery of metformin and rapamycin restore neurodevelopmental homeostasis in autism spectrum disorders. [Abstract]2025 Oct 14;23(1):670. PMID: 41083985 -
Sci Adv
Bacteriocin-transport-inspired oral peptide-probiotic delivery ameliorates IBD complications via autophagy and gut homeostasis. [Abstract]2026 Jan 2;12(1):eadz9069. PMID: 41481708 -
Sci Adv
Endogenous/exogenous dual-responsive nanozyme for photothermally enhanced ferroptosis-immune reciprocal synergistic tumor therapy. [Abstract]2025 May 16;11(20):eadq3870. PMID: 40367177 -
Cell Rep Med
Augment proteasome inhibitor efficacy activates CD8+ T cell-mediated antitumor immunity in breast cancer. [Abstract]2025 Jul 15;6(7):102211. PMID: 40609539 -
Cancer Lett
SLC5A11 mediates metformin-induced PD-L1 suppression to enhance cancer immunotherapy through AMPK-IRF1 signaling. [Abstract]2026 Apr 28:644:218311. PMID: 41690450 -
Cancer Lett
6-Phosphogluconate dehydrogenase promotes glycolysis and fatty acid synthesis by inhibiting the AMPK pathway in lung adenocarcinoma cells. [Abstract]2024 Aug 21:217177. PMID: 39179096 -
Cancer Lett
Acidosis activates breast cancer ferroptosis through ZFAND5/SLC3A2 signaling axis and elicits M1 macrophage polarization. [Abstract]2024 Apr 10:587:216732. PMID: 38360142 -
Cancer Lett
Metformin sensitizes AML cells to chemotherapy through blocking mitochondrial transfer from stromal cells to AML cells. [Abstract]2022 Apr 28:532:215582. PMID: 35122876 -
Cell Death Dis
Mitochondrial oxidative phosphorylation is dispensable for survival of CD34+ chronic myeloid leukemia stem and progenitor cells. [Abstract]2022 Apr 20;13(4):384. PMID: 35444236 -
-
-
Cell Commun Signal
Promoting AMPK/SR-A1-mediated clearance of HMGB1 attenuates chemotherapy-induced peripheral neuropathy. [Abstract]2023 May 4;21(1):99. PMID: 37143083 -
Int J Biol Macromol
Bacterial cellulose membrane integrating phase-transited lysozyme nanofilm loaded with biguanides for dressing treatment of atopic dermatitis. [Abstract]2025 Aug 21;323(Pt 1):147047. PMID: 40848785 -
Acta Pharmacol Sin
Metformin promotes microglial cells to facilitate myelin debris clearance and accelerate nerve repairment after spinal cord injury. [Abstract]2022 Jun;43(6):1360-1371. PMID: 34480113 -
Phytomedicine
Eleutheroside B liposomes ameliorate type 2 diabetes mellitus by modulating glucose and lipid metabolism: A metabolomic study. [Abstract]2025 Nov 27:150:157628. PMID: 41330184 -
Phytomedicine
Lapagyl mitigates UV-induced inflammation and immunosuppression via Foxp3+ Tregs and CCL pathway: A single-cell transcriptomics study. [Abstract]2024 Jul:129:155679. PMID: 38701542 -
Free Radic Biol Med
p67phox/NOX2 inhibits psoriasis by regulating the HIF-1α-glycolysis axis via p53-AMPK in keratinocytes. [Abstract]2025 Sep:237:503-514. PMID: 40516795 -
Food Res Int
Tea drinking effectively improves symptoms of diabetes and prevents hepatorenal damage in mice. [Abstract]2025 Jun:211:116502. PMID: 40356150 -
Sci Total Environ
Mechanisms and targeted reversion/prevention of hepatic fibrosis caused by the non-hereditary toxicity of benzo(a)pyrene. [Abstract]2024 Feb 20:912:169496. PMID: 38135085 -
Brain Behav Immun
Microbial reconstitution reverses prenatal stress-induced cognitive impairment and synaptic deficits in rat offspring. [Abstract]2024 Jun 6:S0889-1591(24)00445-8. PMID: 38851306 -
Emerg Microbes Infect
2022 Dec;11(1):815-828. PMID: 35191819 -
-
Stem Cell Res Ther
The role of PKM2-mediated metabolic reprogramming in the osteogenic differentiation of BMSCs under diabetic periodontitis conditions. [Abstract]2025 Apr 18;16(1):186. PMID: 40251642 -
Stem Cell Res Ther
2025 Jan 23;16(1):20. PMID: 39849625 -
PLoS Biol
The cell cycle regulator PLK1 promotes murine melanoma progression by regulating the transcription factor BACH1. [Abstract]2025 Nov 24;23(11):e3003490. PMID: 41284701 -
-
Cell Rep
circPRKAA1 activates a Ku80/Ku70/SREBP-1 axis driving de novo fatty acid synthesis in cancer cells. [Abstract]2022 Nov 22;41(8):111707. PMID: 36417875 -
J Med Chem
Discovery of IHMT-MST1-58 as a Novel, Potent, and Selective MST1 Inhibitor for the Treatment of Type 1/2 Diabetes. [Abstract]2022 Sep 8;65(17):11818-11839. PMID: 36037148 -
Anal Chem
Noninvasive Dynamic Cell Viability Monitoring Based on Diffraction Height Fingerprint Spectra. [Abstract]2025 Dec 19. PMID: 41417584 -
Antioxidants
Different Effects of Metformin and A769662 on Sodium Iodate-Induced Cytotoxicity in Retinal Pigment Epithelial Cells: Distinct Actions on Mitochondrial Fission and Respiration. [Abstract]2020 Oct 28;9(11):1057. PMID: 33126710 -
Cell Mol Life Sci
Metformin induces tolerogenicity of dendritic cells by promoting metabolic reprogramming. [Abstract]2023 Sep 9;80(10):283. PMID: 37688662 -
Hum Reprod
Metformin inhibits testosterone-induced endoplasmic reticulum stress in ovarian granulosa cells via inactivation of p38 MAPK. [Abstract]2020 May 1;35(5):1145-1158. PMID: 32372097 -
Cancer Cell Int
Icariin exerts anti-tumor activity by inducing autophagy via AMPK/mTOR/ULK1 pathway in triple-negative breast cancer. [Abstract]2024 Feb 14;24(1):74. PMID: 38355608 -
Front Immunol
ATP-Induced Inflammasome Activation and Pyroptosis Is Regulated by AMP-Activated Protein Kinase in Macrophages. [Abstract]2016 Dec 12:7:597. PMID: 28018360
Metformin (glycinate) purchased from MedChemExpress. Usage Cited in: Front Immunol. 2016 Dec 12:7:597. [Abstract]
Metformin increases adenosine triphosphate-induced inflammasome activation in bone marrow-derived macrophages. (A) Cells are treated. Indicated protein levels in both cell lysates and supernatants are evaluated by western blotting. β-Tubulin is used as a loading control for cell lysates. (B–D) The quantitative analyses of the active caspase-1p10 (B), mature interleukin-1β (C), and HMGB1 (D) levels in the supernatants (A) are shown.
-
Chin Med
Berberine ameliorates high-fat diet-induced metabolic disorders through promoting gut Akkermansia and modulating bile acid metabolism. [Abstract]2025 Nov 17;20(1):190. PMID: 41243097 -
Biochem Pharmacol
Crizotinib induces pulmonary toxicity by blocking autophagy flux in alveolar epithelial cells. [Abstract]2023 Sep:215:115636. PMID: 37290598 -
Food Funct
Ameliorative effect of docosahexaenoic acid-acylated astaxanthin ester on diabetic nephropathy: association with the trehalose/HSP90AA1 and colon-kidney axis. [Abstract]2026 May 18. PMID: 42149022 -
J Ethnopharmacol
Shentong Zhuyu Decoction mitigates exercise-induced muscle damage through modulation of AMPK-mediated lipid metabolism and oxidative stress. [Abstract]2026 Feb 28:357:120941. PMID: 41270908 -
Liver Int
Metformin synergistically enhances the antitumour activity of Lenvatinib in hepatocellular carcinoma by altering AKT-FOXO3 signalling pathway. [Abstract]2023 Jul;43(7):1577-1592. PMID: 37208925 -
Biofactors
Metformin and thymoquinone co-treatment enhance 5-fluorouracil cytotoxicity by suppressing the PI3K/mTOR/HIF1α pathway and increasing oxidative stress in colon cancer cells. [Abstract]2023 Jul-Aug;49(4):831-848. PMID: 36929658 -
PLoS Pathog
PoRVA G9P[23] and G5P[7] infections differentially promote PEDV replication by reprogramming glutamine metabolism. [Abstract]2024 Jun 21;20(6):e1012305. PMID: 38905309 -
PLoS Pathog
Picornavirus infection enhances aspartate by the SLC38A8 transporter to promote viral replication. [Abstract]2023 Feb 3;19(2):e1011126. PMID: 36735752 -
Int J Mol Sci
Metformin Alleviates Epirubicin-Induced Endothelial Impairment by Restoring Mitochondrial Homeostasis. [Abstract]2022 Dec 25;24(1):343. PMID: 36613786 -
Biomolecules
Mechanism of Mitophagy to Protect Yak Kidney from Hypoxia-Induced Fibrosis Damage by Regulating Ferroptosis Pathway. [Abstract]2025 Apr 9;15(4):556. PMID: 40305351 -
Biomolecules
2022 Mar 9;12(3):422. PMID: 35327614 -
Int Immunopharmacol
Modified Huanglian Wendan Decoction improves prediabetic renal injury by activating the AMPK/ULK1 pathway to restore autophagy and suppress inflammation. [Abstract]2026 Jun 8:185:116966. PMID: 42259235 -
Int Immunopharmacol
Metformin alleviates inflammatory responses in acute allergic asthma by inhibiting ILC2s function. [Abstract]2025 May 20:159:114897. PMID: 40398255 -
Am J Physiol Cell Physiol
Metformin Mitigates Adipogenesis of Fibro-adipogenic Progenitors After Rotator Cuff Tears Via Activating mTOR/ULK1 Mediated Autophagy. [Abstract]2024 Jun 1;326(6):C1590-C1603. PMID: 38586878 -
Int Immunopharmacol
Boningmycin induces AMPK-mediated endoplasmic reticulum-associated degradation of PD-L1 protein in human cancer cells. [Abstract]2023 Sep 15;124(Pt A):110905. PMID: 37717372 -
Eur J Pharmacol
Alisol B blocks the development of HFD-induced obesity by triggering the LKB1-AMPK signaling in subcutaneous adipose tissue. [Abstract]2023 Oct 5:956:175942. PMID: 37536624 -
Eur J Pharmacol
Idebenone attenuates ferroptosis by inhibiting excessive autophagy via the ROS-AMPK-mTOR pathway to preserve cardiac function after myocardial infarction. [Abstract]2023 Mar 15:943:175569. PMID: 36740037 -
Cell Regen
Cross-species single-cell transcriptomic analysis reveals divergence of cell composition and functions in mammalian ileum epithelium. [Abstract]2022 May 5;11(1):19. PMID: 35511361 -
Front Microbiol
Metformin exacerbates diabetic amyotrophy via oxidative stress and gut microbiota alterations. [Abstract]2026 Apr 13:17:1778515. PMID: 42052385 -
Probiotics Antimicrob Proteins
Potential Benefits of Metformin Via Roseburia Intestinalis in High-fat Diet-fed Mice With Colorectal Adenomas. [Abstract]2025 Nov 26. PMID: 41296177 -
Rheumatology (Oxford)
Metformin attenuates osteoarthritis by targeting chondrocytes, synovial macrophages and adipocytes. [Abstract]2023 Apr 3;62(4):1652-1661. PMID: 35984286 -
Exp Gerontol
Metformin attenuates lens epithelial cell senescence by suppressing cGAS-STING via SIRT1-PGC-1α-mediated mitochondrial fission. [Abstract]2026 Jun 15:219:113157. PMID: 42069238 -
J Inflamm Res
Metformin Attenuates Osteoarthritis Progression by Modulating Mitochondrial Dynamics via Activation of the AMPK/Drp1 Pathway. [Abstract]2026 Feb 2:19:540176. PMID: 41884158 -
J Inflamm Res
Combining Network Pharmacology, Molecular Docking, Molecular Dynamics Simulation, and Experimental Validation to Uncover the Efficacy and Mechanisms of Si-Miao-Yong-An Decoction in Diabetic Wound Healing. [Abstract]2025 Mar 19:18:4087-4101. PMID: 40129870 -
iScience
2025 Apr 3;28(5):112344. PMID: 40276762 -
J Inflamm (Lond)
Emodin alleviates intestinal ischemia-reperfusion injury through antioxidant stress, anti-inflammatory responses and anti-apoptosis effects via Akt-mediated HO-1 upregulation. [Abstract]2024 Jul 9;21(1):25. PMID: 38982499 -
J Cell Physiol
Mitochondrial and Glucose Metabolic Patterns in Pre-Granulosa Cells and Oocytes and Their Dysfunctions Induce Impaired Primordial Follicle Formation in Mice. [Abstract]2025 Nov;240(11):e70110. PMID: 41251108 -
J Drug Target
Dual AMPK activation and TXNIP suppression underlie the superior anti-diabetic action of rosiglitazone-metformin co-crystal (RZM): evidence from preclinical models. [Abstract]2025 Jul 17:1-10. PMID: 40658109 -
Sci Rep
2025 Jul 26;15(1):27294. PMID: 40715275 -
Biomedicines
Metformin Inhibited GSDME to Suppress M2 Macrophage Pyroptosis and Maintain M2 Phenotype to Mitigate Cisplatin-Induced Intestinal Inflammation. [Abstract]2024 Nov 4;12(11):2526. PMID: 39595093 -
-
J Virol
2025 Aug 29:e0052925. PMID: 40879372 -
Cell Signal
AMPK-mediated autophagy pathway activation promotes ΔFosB degradation to improve levodopa-induced dyskinesia. [Abstract]2024 Jun:118:111125. PMID: 38432574 -
Bone
The protection of nicotinamide riboside against diabetes mellitus-induced bone loss via OXPHOS. [Abstract]2025 Jan 28:193:117411. PMID: 39884488 -
Mol Cell Endocrinol
Metformin inhibits cell proliferation and ACTH secretion in AtT20 cells via regulating the MAPK pathway. [Abstract]2024 Mar 1:582:112140. PMID: 38147953 -
Exp Cell Res
NOP14 promotes proliferative diabetic retinopathy through ribosome biogenesis and endothelial dysfunction via Wnt/β-catenin signaling activation. [Abstract]2026 Apr 1;457(1):114922. PMID: 41638389 -
Mol Med Rep
Triptolide promotes ferroptosis by suppressing Nrf2 to overcome leukemia cell resistance to doxorubicin. [Abstract]2023 Jan;27(1):17. PMID: 36453238 -
J Diabetes Res
2026;2026(1):e2226729. PMID: 42237524 -
Appl Biochem Biotechnol
Knocking Down CDKN2A Enhances the Therapeutic Effects of Metformin and Resveratrol on Diabetic Retinopathy. [Abstract]2026 Mar 17. PMID: 41843007 -
-
Biochim Biophys Acta Mol Cell Biol Lipids
Oroxylin A ameliorates non-alcoholic fatty liver disease by modulating oxidative stress and ferroptosis through the Nrf2 pathway. [Abstract]2025 May 12:159628. PMID: 40368273 -
Front Oncol
Metformin Downregulates PD-L1 Expression in Esophageal Squamous Cell Catrcinoma by Inhibiting IL-6 Signaling Pathway. [Abstract]2021 Nov 22;11:762523. PMID: 34881181 -
Environ Toxicol
Metformin and chidamide synergistically suppress multiple myeloma progression and enhance lenalidomide/bortezomib sensitivity. [Abstract]2024 Apr;39(4):2452-2465. PMID: 38251764 -
Environ Toxicol
Pretreatment with metformin prevents microcystin-LR-induced tau hyperphosphorylation via mTOR-dependent PP2A and GSK-3β activation. [Abstract]2021 Dec;36(12):2414-2425. PMID: 34432352 -
Naunyn Schmiedebergs Arch Pharmacol
Protective effect of orientin on diabetic nephropathy in rat models of high-fat diet and streptozotocin-induced diabetes. [Abstract]2025 Mar 4. PMID: 40035824 -
J Neuropathol Exp Neurol
Downregulating Cdk5 reverses hippocampal neuron ferroptosis by regulating the AMP-activated protein kinase pathway and "M1" polarized microglia. [Abstract]2025 Aug 19:nlaf092. PMID: 40829042 -
Curr Issues Mol Biol
Gypenosides Alleviate Hyperglycemia by Regulating Gut Microbiota Metabolites and Intestinal Permeability. [Abstract]2025 Jul 3;47(7):515. PMID: 40728984 -
Breast Cancer Res Treat
2025 Jun;211(2):467-478. PMID: 40055251 -
Mol Reprod Dev
Effect of berberine combined with metformin on autophagy in polycystic ovary syndrome by regulating AMPK/AKT/mTOR pathway. [Abstract]2024 Aug;91(8):e23768. PMID: 39155689 -
Arch Biochem Biophys
FAM98A promotes resistance to 5-fluorouracil in colorectal cancer by suppressing ferroptosis. [Abstract]2022 Jun 15;722:109216. PMID: 35421356 -
Oral Dis
Metformin overcomes chemoresistance by regulating stemness via KLF4 in oral squamous cell carcinoma. [Abstract]2025 Feb;31(2):468-481. PMID: 39039738 -
J Appl Toxicol
Capacitation-Induced Changes in Sperm Motility, AMPK Phosphorylation, and Tyrosine Phosphorylation Are Diminished by Therapeutically Relevant Concentrations of Metformin. [Abstract]2026 Feb 2. PMID: 41628886 -
Neuroscience
Protective effects of PIK3CG knockdown against OGD/R-induced neuronal damage via inhibition of autophagy through the AMPK/mTOR pathway. [Abstract]2025 Jan 26:565:91-98. PMID: 39603405 -
J Chromatogr B Analyt Technol Biomed Life Sci
Integrated HPLC, pharmacodynamics, and immunoprofiling to explore active components and mechanism of Zhi Bai Heye Fang on glycolipid metabolic disorders in mice. [Abstract]2024 Dec 28:1252:124446. PMID: 39754817 -
J Orthop Surg Res
Molecular mechanisms of AMPK/YAP/NLRP3 signaling pathway affecting the occurrence and development of ankylosing spondylitis. [Abstract]2023 Nov 4;18(1):831. PMID: 37925428 -
Genes (Basel)
2022 Dec 16;13(12):2384. PMID: 36553651 -
Onco Targets Ther
Metformin Promotes Beclin1-Dependent Autophagy to Inhibit the Progression of Gastric Cancer. [Abstract]2020 May 19;13:4445-4455. PMID: 32547075 -
J Integr Neurosci
Roles of Metformin and Pioglitazone in Regulating A1-like Astrocyte Activation in EAE Mice. [Abstract]2026 Apr 13;25(4):47364. PMID: 42052770 -
PLoS One
Development of a cell-free screening assay for the identification of direct PERK activators. [Abstract]2023 May 18;18(5):e0283943. PMID: 37200357 -
Cell Biochem Biophys
Metformin Inhibits the Development of Helicobacter pylori-Associated Gastritis by Regulating the ERK-MMP10-IL-1β Axis. [Abstract]2025 Apr 4. PMID: 40180700 -
Oncol Lett
Metformin inhibits epithelial-mesenchymal transition of oral squamous cell carcinoma via the mTOR/HIF-1α/PKM2/STAT3 pathway. [Abstract]2021 Jan;21(1):31. PMID: 33262823 -
Biochem Bioph Res Co
Combination of metformin and RG7388 enhances inhibition of growth and induction of apoptosis of ovarian cancer cells through the PI3K/AKT/mTOR pathway. [Abstract]2020 Dec 17;533(4):665-671. PMID: 33051060 -
Biochem Cell Biol
NDUFA4 promotes the progression of head and neck paraganglioma by inhibiting ferroptosis. [Abstract]2023 Dec 1;101(6):523-530. PMID: 37602474 -
Stem Cells Dev
Metformin Rescues the Impaired Osteogenesis Differentiation Ability of Rat Adipose-Derived Stem Cells in High Glucose by Activating Autophagy. [Abstract]2021 Oct 15;30(20):1017-1027. PMID: 34486387 -
Cancer Rep (Hoboken)
Identification of Androgen Receptor as a Molecular Docking Target for Survival and Response to Metformin-Induced Ferroptosis in Liver Cancer. [Abstract]2025 Jul;8(7):e70245. PMID: 40583627 -
Virus Genes
AMP-activated kinase regulates porcine reproductive and respiratory syndrome virus infection in vitro. [Abstract]2022 Apr;58(2):133-142. PMID: 35254586 -
-
-
-
-
-
-
-
-
bioRxiv
2025 Aug 25:2025.08.21.671520. PMID: 40909720 -
-
-
-
-
-
-
-
-
-
-
-
Ann Transl Med
Metformin alleviates bevacizumab-induced vascular endothelial injury by up-regulating GDF15 and activating the PI3K/AKT/FOXO/PPARγ signaling pathway. [Abstract]2021 Oct;9(20):1547. PMID: 34790753 -
-
Purity & Documentation
References
[1]. Soraya H, et al. Acute treatment with metformin improves cardiac function following isoproterenol induced myocardial infarction in rats. Pharmacol Rep. 2012;64(6):1476-84. [Content Brief]
[2]. Quaile MP, et al. Toxicity and toxicokinetics of metformin in rats. Toxicol Appl Pharmacol. 2010 Mar 15;243(3):340-7. [Content Brief]
[3]. Xue J, et al. Metformin inhibits growth of eutopic stromal cells from adenomyotic endometrium via AMPK activation and subsequent inhibition of AKT phosphorylation: a possible role in the treatment of adenomyosis. Reproduction. 2013 Aug 21;146(4):397-406. [Content Brief]
[4]. Otto M, et al. Metformin inhibits glycogen synthesis and gluconeogenesis in cultured rat hepatocytes. Diabetes Obes Metab. 2003 May;5(3):189-94. [Content Brief]
[5]. Avci CB, et al. Therapeutic potential of an anti-diabetic drug, metformin: alteration of miRNA expression in prostate cancer cells. Asian Pac J Cancer Prev. 2013;14(2):765-8. [Content Brief]
[6]. Abdel-Zaher AO, et al. Novel mechanistic insights of the potential role of gasotransmitters and autophagy in the protective effect of metformin against hepatic ischemia/reperfusion injury in rats. Naunyn Schmiedebergs Arch Pharmacol. 2025 Feb 6. [Content Brief]
[7]. Liu J, et al. Metformin inhibits renal cell carcinoma in vitro and in vivo xenograft. Urol Oncol. 2013 Feb;31(2):264-70. [Content Brief]
[8]. Lin HY, et al. Low-dose metformin requires brain Rap1 for its antidiabetic action. Sci Adv. 2025 Aug;11(31):eadu3700. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)